Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. Article

authors

  • Dudley, ME
  • Gross, CA
  • Somerville, RP
  • Hong, Y
  • Schaub, NP
  • Rosati, SF
  • White, DE
  • Nathan, D
  • Restifo, NP
  • Steinberg, SM
  • Wunderlich, JR
  • Kammula, US
  • Sherry, RM
  • Yang, JC
  • Phan, GQ
  • Hughes, Marybeth S.
  • Laurencot, CM
  • Rosenberg, SA

publication date

  • 2013

published in

PubMed Central ID

  • pmc3731980

start page

  • 2152

end page

  • 9

volume

  • 31

issue

  • 17